Telmisartan + Amlodipine + Bisoprolol Tablet Franchise in Ahmedabad

Cardiac Care Tablet Supplier in Mumbai

Hypertension Medicine Distributor in Delhi

Cardiology Pharma Franchise in Bangalore

Telmisartan Amlodipine Tablet Stockist in Hyderabad
Cardiac Care Tablet Manufacturer & Exporter in Chandigarh

Home/Products /telmisartan-40mg-amlodipine-5mg-bisoprolol-2-5mg-tablet

About the Product

Description


Telbolife AB 2.5 Tablet contains Telmisartan 40mg + Amlodipine 5mg + Bisoprolol 2.5mg, a triple-action therapy designed for effective hypertension management and overall cardiac health support. Telmisartan blocks angiotensin receptors to reduce blood pressure, Amlodipine relaxes blood vessels for improved circulation, and Bisoprolol regulates heart rate, providing comprehensive cardiovascular control.

This combination ensures enhanced therapeutic benefits and is highly trusted by prescribers, generating consistent demand. Patients benefit from better blood pressure control, reduced cardiovascular risk, and improved adherence to therapy.

For franchise partners, Telbolife AB 2.5 Tablet represents a high-demand cardiac care product with strong market acceptance. Its proven clinical performance and prescriber confidence make it a profitable addition to cardiovascular portfolios, helping expand business opportunities and attract loyal clients.

With its comprehensive cardiac protection, Telbolife AB 2.5 Tablet offers sustainable sales growth, making it an ideal choice for partners targeting hypertension and cardiac care markets.

Common side effects may include dizziness, fatigue, headache, palpitations, flushing, and mild swelling of the ankles. Less common side effects include hypotension, bradycardia, or gastrointestinal disturbances. Severe or persistent symptoms should be reported immediately to a healthcare professional.

Telbolife AB 2.5 Tablet is indicated for the management of essential hypertension, especially in patients who require combination therapy for optimal blood pressure control. It is also beneficial for patients with additional cardiovascular risk factors, including diabetes, coronary artery disease, or chronic kidney disease.

Telbolife AB 2.5 Tablet should be taken exactly as prescribed. Regular monitoring of blood pressure, heart rate, and kidney function is recommended. Do not discontinue therapy abruptly without consulting a doctor, as this may worsen cardiovascular conditions.

Store Telbolife AB 2.5 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Telmisartan 40mg + Amlodipine 5mg + Bisoprolol 2.5mg Tablet in the PCD pharma franchise market?

Telmisartan 40mg + Amlodipine 5mg + Bisoprolol 2.5mg Tablet has strong demand in the cardiology, hypertension management, and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cardiovascular healthcare portfolios.

Why should medical distributors include Telmisartan 40mg + Amlodipine 5mg + Bisoprolol 2.5mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for hypertension and cardiovascular risk management under medical supervision. Telmisartan 40mg is an angiotensin II receptor blocker (ARB) that helps relax blood vessels and lower blood pressure Amlodipine 5mg is a calcium channel blocker that improves blood flow and assists in blood pressure control Bisoprolol 2.5mg is a cardioselective beta-blocker that helps reduce heart rate and cardiac workload The triple-drug combination offers complementary mechanisms to support effective blood pressure management Commonly prescribed for patients with hypertension who require combination therapy to achieve optimal blood pressure control Helps improve patient convenience and compliance by reducing pill burden Widely prescribed by cardiologists, physicians, and general practitioners This strengthens a comprehensive cardiology and chronic care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Telmisartan 40mg + Amlodipine 5mg + Bisoprolol 2.5mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong prescription demand in cardiology practice, long-term therapy usage, repeat prescriptions, reliable supply chain support, and attractive margins in the cardiovascular segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.